Dana-Farber Cancer Institute
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Dana-Farber Cancer Institute
May 25, 2024, 11:11 |
Societies
Chiara Corti endorses Giuseppe Curigliano for the ESMO Presidental election
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: . "I…
May 25, 2024, 07:41 |
Insight
Paolo Tarantino: I’m extremely excited to support Giuseppe Curigliano for the next ESMO Presidential Elections!
Paolo Tarantino shared on LinkedIn: “I’m extremely excited to support Giuseppe Curigliano for the next…
May 24, 2024, 19:29 |
Insight
Toni Choueiri: Make sure to attend this session on Celebrating, and Supporting IMGs in Oncology during ASCO24
Toni Choueiri shared a post on X: “Make sure to attend this session on Recognizing, Celebrating,…
May 24, 2024, 12:47 |
Positive
Ann Partridge was selected for a Research Professorship by the American Cancer Society - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X: "Congratulations to Ann Partridge MD who was selected for…
May 24, 2024, 06:53 |
Insight
Daniel Stover: IMG representation at international oncology conferences
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
May 23, 2024, 14:29 |
Societies
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…
May 23, 2024, 11:01 |
Insight
Paolo Tarantino: More than 10,000 downloads for our editorial on the “5 S rules” to manage ILD
Paolo Tarantino shared on X: "More than 10,000 downloads for our editorial on the “5…
May 22, 2024, 14:42 |
Blog
eFFECTOR Therapeutics announces the initiation of an investigator-sponsored trial in collaboration with the Dana-Farber Cancer Institute
eFFECTOR Therapeutics shared a post on LinkedIn: "We are excited to announce the initiation of an…
May 21, 2024, 14:19 |
Blog
Alberto Güijosa: I will be joining Dana-Farber Cancer Institute as a postdoctoral research fellow
Alberto Güijosa, Medical Student at Pan American University Mexico City, shared a post on X: "Thrilled…
May 21, 2024, 10:33 |
Blog
Inauguration of the Dana-Farber International Patient Center
Dana-Farber Cancer Institute shared a post on LinkedIn: "We were honored to welcome guests and…
May 21, 2024, 06:07 |
Insight
Paul Nguyen: Sending love and admiration for the greatest GU scientist Felix Feng
Paul Nguyen, Prostate Cancer radiation oncologist at Dana-Farber Cancer Institute and Brigham and Women's Hospital,…
May 20, 2024, 14:34 |
Blog
Evolving Concepts in Meningioma Management in the Era of Genomics - ACS Journal Cancer
ACS Journal Cancer shared the following on X: "This new review article from Mass General…
May 20, 2024, 03:52 |
Blog
Dana-Farber Cancer Institute - patients interactions with Dana-Farber volunteers
Dana-Farber Cancer Institute shared a post on LinkedIn: "Ask patients and loved ones about their interactions…
May 20, 2024, 00:12 |
Blog
Maria Babak: Catch up on this weeks updates from The Babak Lab!
Maria Babak, Head of the Drug Discovery Lab at the City University of Hong Kong,…
May 18, 2024, 12:07 |
Insight
Amer Zeidan: Another great project led by super star Maximilian Stahl
Amer Zeidan shared a post on X: “Another great project led by super star Maximilian Stahl…
May 18, 2024, 10:02 |
Societies
Matteo Lambertini: What a big honor to have Sara Tolaney at our ESMOYOC session
Matteo Lambertini, Medical Oncologist at San Martino, shared on X: . "What a big honor…
May 18, 2024, 02:38 |
Blog
Dana-Farber Cancer Institute extends deep gratitude to His Royal Highness and the Department of Health Abu Dhabi
Dana-Farber Cancer Institute shared on LinkedIn: "Laurie H. Glimcher, MD, President and CEO of Dana-Farber Cancer…
May 18, 2024, 02:12 |
Blog
Paolo Tarantino: Important subanalysis of SOFT/TEXT presented by Otto Metzger
Paolo Tarantino shared on X: "Important subanalysis of SOFT/TEXT presented by Otto Metzger from Dana-Farber’s…
May 17, 2024, 11:41 |
Insight
Sara Tolaney: Helpful discussion by Cristina Saura on how to think about adjuvant therapies in patients with gBRCAm
Sara Tolaney shared a post on X: “Very helpful discussion by Cristina Saura on how…
May 16, 2024, 11:06 |
Societies
Stephanie Graff: Chairs kick off ESMOBreast24
Paolo Tarantino shared a post by Stephanie Graff on X, adding: . "Impressive continuous growth…
May 16, 2024, 06:24 |
Blog
Emre Yekedüz: A great summary by Niklas Klümper, Viktor Grüenwald and team about the role of MMR/MSI
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer…
May 15, 2024, 14:42 |
Blog
Katya Losk: Dana-Farber Cancer Institute is honored to participate in Abu Dhabi Global Healthcare Week
Katya Losk, Senior Director of International Strategic Initiatives at Dana-Farber Cancer Institute, shared a post…
May 15, 2024, 12:22 |
Blog
The Babak Lab - Exciting Progress in Melanoma Treatment: Personalized Vaccines Show Promise
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 15, 2024, 11:51 |
Blog
Allison Chang: Can’t wait to go back with ALCSI next year!
Allison Chang, Thoracic Oncology Fellow at Dana-Farber Cancer Institute, shared a post by ALCSI on X/Twitter:…
May 13, 2024, 07:12 |
Blog
Paolo Tarantino: DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my friend and mentor of many years Giuseppe Curigliano
Paolo Tarantino shared on X: "DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my…
May 12, 2024, 13:30 |
Blog
Biagio Ricciuti: Insightful discussions at Rome Lung 24
Biagio Ricciuti shared a post by Stephen Liu on X and added: "Had a great…
May 11, 2024, 13:57 |
Blog
Michelle Tucker’s inspiring story of becoming a nurse - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on LinkedIn: "Michelle Tucker, BSN, RN, (right) wanted to be a nurse…
May 11, 2024, 11:39 |
Blog
Julia Maués: HER2-positive, HER2-low, HER2-shy
Julia Maués, Co-Founder of Grasp Cancer, shared a post by Paolo Tarantino on X and…
May 11, 2024, 11:23 |
Insight
Matt Sagan: Moving from HER2+ to HER2-low to HER2- ultralow
Matt Sagan, Co-Founder and CEO of FiBioMed, shared a post by Paolo Tarantino on X,…
May 11, 2024, 03:04 |
Blog
Warm welcome to Derek Lynch, our new Program Director for the Richi House initiative - Richi Childhood Cancer Foundation
Richi Childhood Cancer Foundation shared a post on LinkedIn: ''We're thrilled to announce a new addition…
May 10, 2024, 11:08 |
Blog
Laurie Glimcher: Steven Caltrider was selected as a 2024 In-House Leaders in the Law by Mass
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared a post on X: "Congratulations to…
May 7, 2024, 11:51 |
Positive
Sara Tolaney: HAPPY NURSES WEEK!
Sara Tolaney shared a post on X: "HAPPY NURSES WEEK! A special thank you to…
May 7, 2024, 11:33 |
Blog
Douglas Flora: The research you’ve performed, and published is changing the way cancer patients are treated around the world
Douglas Flora shared a post by Jaime Grund, Director of St. Elizabeth Healthcare, on LinkedIn: "Patients are safer…
May 7, 2024, 10:51 |
Blog
Maximilian Stahl: I’ll be at the Oncology Symposia in Conjunction With the 2024 ASCO Annual Meeting
Maximilian Stahl, Attending Physician in the Department of Medical Oncology at Dana-Farber Cancer Institute, shared…
May 7, 2024, 10:25 |
Career
Tom Powles has been named in TIME100 Health - Barts and The London School of Medicine and Dentistry
Toni Choueiri shared a post by Barts and The London School of Medicine and Dentistry…
May 6, 2024, 10:15 |
Insight
Monica Bertagnolli: I spoke with members of Congress about Funding
Monica Bertagnolli shared a post on LinkedIn: “I spoke with members of Congress this week about…
May 5, 2024, 12:04 |
Blog
Piotr Wysocki: Elective Pelvic Lymph Node Radiation for elderly patients with prostate cancer
Piotr Wysocki recently shared on LinkedIn: "Sayan M et al. analyzed individual patient data from a…
May 5, 2024, 07:14 |
Blog
Dana-Farber Cancer Institute - Edward Chouchani receiving the 2024 Emerging Leader Awards from The Mark Foundation
Dana-Farber Cancer Institute shared a post on LinkedIn: "Edward Chouchani, PhD, of Cancer Biology and associate…
May 5, 2024, 05:09 |
Blog
Todd Golub has been named to the National Academy of Sciences - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on their LinkedIn: ''Dana-Farber’s Todd Golub has been named to the…
May 3, 2024, 16:17 |
Blog
Paolo Tarantino: HER2-low: should we even test?
Paolo Tarantino shared a post on X: "The timing couldn’t be more appropriate for this…
May 3, 2024, 10:40 |
Blog
Harold J. Burstein: USPSTF finally catches up in recommending mammograms starting at age 40
Harold J. Burstein, Breast cancer specialist and professor Dana Farber Cancer Institute and Harvard Medical School,…
May 2, 2024, 16:48 |
Insight
Vinayak Venkataraman: Appreciated the chance to speak at the 20th Annual Young Adult Cancer Conference
Vinayak Venkataraman, Medical Oncologist in the Sarcoma Center at Dana-Farber Cancer Institute, shared on X:…
May 2, 2024, 01:48 |
Blog
Dana-Farber Breast Oncology Center - Breast Cancer Research Digest
Dana-Farber Breast Oncology Center shared on X: "Here's the Breast Cancer Research Digest - a…
May 1, 2024, 16:28 |
Career
Toni Choueiri: The Dana-Farber Lank Center for Genitourinary Oncology is hiring again
Toni Choueiri shared on X: “Well, the Dana-Farber Lank Center for Genitourinary Oncology is hiring…
May 1, 2024, 04:54 |
Blog
Howard McLeod: Preemptive DPYD Testing Program for patients planned for a systemic Fluoropyrimidine
Howard McLeod, Central Director, Founder and Advisor at Precision Medicine, shared on LinkedIn: “The USA…
May 1, 2024, 01:17 |
Blog
Jun Qi: Our article on EP300/CBP bromodomain inhibition in Group 3 medulloblastoma is now published
Jun Qi, Assistant Professor of Medicine at Dana-Farber Cancer Institute, shared a post on LinkedIn:…
Apr 30, 2024, 12:22 |
Insight
Harold Burstein: ER-low tumors will require chemotherapy and endocrine therapy
Harold Burstein, Breast Cancer Specialist and Professor at Dana Farber Cancer Institute, shared a post…
Apr 29, 2024, 15:12 |
Blog
Damon Runyon Cancer Research Foundation 2024 Quantitative Biology Fellow - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Congratulations to Dana-Farber's Ahmed Roman, PhD, who…
Apr 28, 2024, 11:48 |
Drugs
Tovorafenib has now been approved for young patients with relapsed or progressive pediatric low-grade glioma - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute recently shared on LinkedIn: "For more than a decade, a collaborative team…
Apr 28, 2024, 11:19 |
Blog
Paolo Tarantino: Truly groundbreaking work that turned a failed chemotherapy in one of the most active anticancer drugs ever developed
Paolo Tarantino shared a post by Florian Muller, Co-Head of Biology at Powder Gate Discovery, on…
Apr 27, 2024, 14:14 |
Blog
Registration is open for NANETS. Regional NET Education Program in Providence - Yale Cancer Center
Pamela Kunz shared a post by Yale Cancer Center, on X: "Please join us for this great…
Apr 26, 2024, 17:44 |
Drugs
Paolo Tarantino: The agnostic potential of Antibody Drug Conjugates with Roberto Carmagnani Pestana, MD is among the most cited of 2022-2023 on CA - A Cancer Journal for Clinicians
Apr 26, 2024, 10:00 |
Insight
Biagio Ricciuti: Our work on long-term outcomes to PD-1 monotherapy by increasing PD-L1 levels in NSCLC is out in JTO and JTO CRR
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''Our work on long-term…
Apr 23, 2024, 16:24 |
Blog
Renee Maria Saliby: Enthusiastic about joining Yale Traditional Internal Medicine Program after listening to the 'State of the Cancer Center' by Eric Winer
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Apr 22, 2024, 11:46 |
Blog
Paolo Tarantino: The unmissable Harvard University breast cancer course is coming back on July 11-12
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared on X: "The unmissable Harvard…
Apr 22, 2024, 11:40 |
Blog
Sara Tolaney: Very excited to have Aleix Prat as the Schlager Lecturer at the Harvard Breast Course in July!
Sara Tolaney shared a post by Aleix Prat, Co-Founder of Reveal Genomics, on X/Twitter, adding:…
Apr 21, 2024, 08:54 |
Insight
Rana McKay wins the 2024 Christopher G. Wood Rising Star Award at IKCS Europe
Rana McKay won the 2024 Christopher G. Wood Rising Star Award at IKCS Europe, which…
Apr 20, 2024, 20:17 |
Insight
Paolo Tarantino: Tumor-infiltrating lymphocytes (TILs): not only prognostic in Triple-Negative Breast Cancer
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Tumor-infiltrating lymphocytes (TILs): not…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 20, 2024, 01:23 |
Positive
Stuart H. Orkin was named one of TIME's 100 Most Influential People of 2024 - Dana-Farber News
Quoting Dana-Farber News on X/Twitter: "Congratulations to Dana-Farber Cancer Institute's Stuart H. Orkin, MD, who…
Apr 19, 2024, 08:07 |
Insight
Toni Choueiri: An inspiration to all trainees
Toni Choueiri, shared a post by Ziad Bakouny, Hematology/Oncology fellow at Memorial Sloan Kettering Cancer Center,…
Apr 18, 2024, 19:48 |
Blog
Join Dana-Farber Cancer Institute in Boston on June 10-12 for Cancer Immunotherapy: From Bench to Bedside and Back
Dana-Farber Cancer Institute shared a post on LinkedIn: "Join us in Boston on June 10-12 for…
Apr 18, 2024, 17:03 |
Insight
Marc Eid: Stellar talk by Jacob Berchuck during Transatlantic exchange 2024
Marc Eid, Postdoctoral research fellow in Medical Oncology at the Dana-Farber Cancer Institute, shared on…
Apr 17, 2024, 11:47 |
Blog
The collaboration that ultimately led to a phase II clinical trial at Massachusetts General Hospital, where Serena found her miracle - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn: "David DiCillo (Dave) and Michael Tucker (Mike) are…
Apr 17, 2024, 10:09 |
Positive
Yaniss B.: The 3rd edition of the Transatlantic Exchanges in Oncology was a huge success!
Yaniss B, Valorisation Officer at Gustave Roussy Transfert shared on X: “The 3rd edition of the…
Apr 16, 2024, 13:22 |
Blog
Toni Choueiri: And that is a wrap for the Transatlantic conference between Dana-Farber, Gustave Roussy
Toni Choueiri shared on their X/Twitter: ''And that is a wrap for the Transatlantic conference…
Apr 16, 2024, 13:14 |
Blog
Rashad Nawfal: Ending the Transatlantic Exchange 2024 on a high note with an outstanding talk by Sylvan Baca
Rashad Nawfal, Postdoctoral Research Fellow at Dana Farber Cancer Institute, shared on their X/Twitter: ''Ending…
Apr 16, 2024, 12:58 |
Drugs
Emre Yekedüz: A retrospective study from Gustave Roussy
Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer…
Apr 16, 2024, 11:06 |
Blog
Paolo Tarantino: Outstanding presentation on MRD/ctDNA by Heather Parsons at the 3rd Transatlantic Exchange in Oncology
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Outstanding presentation on…
Apr 16, 2024, 02:27 |
Blog
Dana-Farber Cancer Institute and Gustave Roussy are proud to share their progress in cancer treatment
Gustave Roussy shared on X/Twitter: "Launch of the Third Transatlantic exchange in Oncology in Boston. Dana-Farber…
Apr 16, 2024, 01:37 |
Blog
Did you know Robert Haddad and Toni Choueiri had a competitive streak? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Did you know Robert Haddad and Toni…
Apr 16, 2024, 00:17 |
Blog
Paolo Tarantino: We review best practices and future perspectives for the identification of patients with HER2-low Breast Cancer
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, posted on LinkedIn: "In our latest…
Apr 15, 2024, 12:53 |
Opinion
Nikhil C. Munshi: Getting MRD as an endpoint was a great partnership between academia and industry and patient organization
Nikhil C. Munshi, Associate Director of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber…
Apr 14, 2024, 13:47 |
Insight
Paolo Tarantino: Do patients with these small triple-negative tumors benefit from chemotherapy?
Paolo Tarantino, Research Fellow presso Dana-Farber Cancer Institute, shared a post on LinkedIn: "One third of…
Apr 14, 2024, 10:33 |
Opinion
Elad Sharon: Designing clinical trials is all about tradeoffs
Elad Sharon, Clinical and Translational Director of Immunotherapy Toxicity Service at Dana-Farber Cancer Institute, shared…
Apr 13, 2024, 10:28 |
Opinion
Toni Choueiri: Wonderful pickleball game to benefit Dana-Farber Cancer Institute and The Jimmy Fund
Toni Choueiri shared a post on LinkedIn: "Thank you Rob Gronkowski and Julian Edelman for…
Apr 12, 2024, 03:19 |
Dialogues
OncoInfluencers: Dialogue with Pasi Jänne, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In…
Apr 11, 2024, 17:23 |
Blog
Toni Choueiri: Back in business - The SOCCER ASCO game is back during ASCO24
Toni Choueiri recently shared a post on X: "Back in business: The SOCCER ASCO game…
Apr 11, 2024, 17:15 |
Blog
Oyepeju Abioye: 'Precision Immuno-Oncology in NSCLC through Gender Equity Lenses', published in MDPI
Oyepeju Abioye, Oncology Clinical Research Assistant at Florez Laboratory of Dana-Farber Cancer Institute, shared on X:…
Apr 11, 2024, 12:45 |
Insight
Important IMvoke010 trial could shape future research in immunotherapy in locally advanced head and neck cancer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X/Twitter: "Important IMvoke010 trial could shape future research in immunotherapy…
Apr 10, 2024, 08:56 |
Career
Pasi Jänne was recently recognised with the ACS 2024 Medal of Honour Award - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Pasi Jänne, senior vice president for Translational…
Apr 10, 2024, 05:06 |
Insight
Toni Choueiri: The Renee Saliby kidney cancer biomarker paper in Cancer Cell is online with a detailed tweetorial
Toni Choueiri shared a post by Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber…
Apr 10, 2024, 05:00 |
Blog
Paolo Tarantino: Our study on the prognosis of small TNBCs is out in NPJ Journals
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "Our study…
Apr 9, 2024, 13:33 |
Blog
Biagio Ricciuti: If you are at AACR24, stop by poster 21 (section 1) to learn more about the discovery of ALK-specific TCR clonotypes
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''If you are at…
Apr 8, 2024, 23:10 |
Blog
Biagio Ricciuti: MET kinase domain mutations as novel and targetable alterations in NSCLC
Biagio Ricciuti, Medical oncologist at Dana-Farber Cancer Institute, shared a post on LinkedIn: "Our collaborative effort…
Apr 8, 2024, 22:02 |
Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Apr 8, 2024, 11:46 |
Blog
Elad Sharon: Listening to my mentee, Rafeh Naqash, present some incredible data at the SWOG plenary!
Elad Sharon, Clinical and Translational Director at Dana-Farber Cancer Institute, shared a post on X: "Listening to…
Apr 8, 2024, 03:54 |
Drugs
Paolo Tarantino: Trastuzumab deruxtecan is now FDA approved for ANY treatment-refractory HER2+ solid tumor
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Apr 4, 2024, 13:16 |
Blog
Gevorg Tamamyan: It was a great pleasure interviewing Pasi Jänne
Gevorg Tamamyan shared on LinkedIn: "It was a great pleasure interviewing Pasi Jänne, a world-known…
Apr 2, 2024, 05:37 |
Drugs
Paolo Tarantino: The OXEL trial is out on Nature Communications
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Apr 1, 2024, 23:34 |
Opinion
Harold Burstein: What the Princess of Wales can teach us all about a cancer diagnosis
Harold Burstein, Breast cancer specialist and professor Dana-Farber Cancer Institute and Harvard Medical School, shared…
Mar 31, 2024, 14:23 |
Blog
Dana-Farber Cancer Institute: Five Dana-Farber scientists have been chosen to receive Wong Family Awards in Translational Oncology for fiscal year 2024
Dana-Farber Cancer Institute posted on LinkedIn: "Five Dana-Farber scientists have been chosen to receive Wong…
Mar 30, 2024, 14:12 |
Blog
Jennifer Buell: I ride in the Pan Mass Challenge to eliminate the premature loss of so many important lives, to stand with our fighters, to illuminate hope
Jennifer Buell, the President and Chief Executive Officer of MiNK Therapeutics, shared on LinkedIn: "I…
Mar 28, 2024, 13:57 |
Blog
Dana-Farber Cancer Institute Earns Fifth Consecutive 𝗠𝗮𝗴𝗻𝗲𝘁® Designation
Dana-Farber Cancer Institute made the following on LinkedIn: “𝗗𝗮𝗻𝗮-𝗙𝗮𝗿𝗯𝗲𝗿 𝗖𝗮𝗻𝗰𝗲𝗿 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗘𝗮𝗿𝗻𝘀 𝗙𝗶𝗳𝘁𝗵 𝗖𝗼𝗻𝘀𝗲𝗰𝘂𝘁𝗶𝘃𝗲 𝗠𝗮𝗴𝗻𝗲𝘁® 𝗗𝗲𝘀𝗶𝗴𝗻𝗮𝘁𝗶𝗼𝗻…
Mar 27, 2024, 14:11 |
Blog
Stephen V Liu: ELCC24 Great discussion of Antibody drug conjugates toxicity from Dr. Jarushka Naidoo, noting that each component of the antibody drug conjugate will impact toxicity
Mar 27, 2024, 14:04 |
Blog
Idalid Franco: Applications for CancerGRACE's Patient Education Ambassador Program are open
Idalid Franco shared a post by CancerGRACE on X, adding: "Applications for CancerGRACE's Patient Education…
Mar 26, 2024, 18:28 |
Blog
Ines Vaz-Luis Receives the 2024 ASCO International Women Who Conquer Cancer Mentorship Award
The American Society of Clinical Oncology (ASCO) has announced Ines Vaz-Luis, MD, PhD, as the recipient of…
Mar 26, 2024, 05:00 |
Blog
Toni Choueiri: Major Victory for kidney cancer research Funding! 50 million Dollars Awarded!
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Mar 25, 2024, 15:55 |
Career
Philip Kantoff Receives the 2024 ASCO Excellence in Teaching Award
The American Society of Clinical Oncology (ASCO) has announced Philip Kantoff, MD as the recipient of…
Mar 24, 2024, 08:23 |
Drugs
Paolo Tarantino: Adding palbociclib to fulvestrant did not improve PFS in the PACE randomized phase 2 trial
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
1
2
3
All:
263
Posts:
101 - 200
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube